Zoetis (Public - NYSE:ZTS) is a global animal health company dedicated to supporting customers and their businesses in ever better ways. Building on 60 years of experience, we deliver quality medicines and vaccines, complemented by diagnostic products and genetic tests and supported by a range of services. We are working every day to better understand and address the real-world challenges faced by those who raise and care for animals in ways they find truly relevant.
Our name, Zoetis (zo-EH-tis), has its root in zo, familiar in words such as zoo and zoology and derived from zoetic, meaning “pertaining to life.” It signals our company’s dedication to supporting the veterinarians and livestock producer.
The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company operates in 70 countries worldwide with recent expansions intoSoutheast Asia and China. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index
July 2020 - Zoetis Acquires Fish Vet Group to Enhance Aquaculture Diagnostic Capabilities
Additional Labs and Environmental Testing Further Complement Pharmaq’s Offering to Fish Producers in Key Aquaculture Markets
Europêche calls for a level playing field at EU-China Blue Forum European Union
The Chinese Ministry of natural resources and the European Commission organised last Saturday in Shenzhen (China) the second Ocean Forum under the EU-China Blue Partnership for the Oceans. The goal: t...
Germany ranked 2nd in importing Vietnamese pangasius in the EU Viet Nam
According to statistics from Vietnam Customs, accumulated in the first 8 months of 2023, pangasius exports to Germany reached 23 million USD, up 19% over the same period last year, accounting for 2%. ...